CRONIC-PPF.at

Welcome

Description

Projects

Education

Faculty

• Bärnthaler
• Biasin
• Böhm
• Gorkiewicz
• Heinemann
• Heitzer
• Kargl
• Kneidinger
• Kovács
• Kwapiszewska
• Marsh
• Milger
• Sattler
• Singer
• Vesely

Supporting Members

Students

Publications

 

• Webmaster

The CRONIC-PPF Faculty

Julia KARGL (former STURM)
Assoz. Prof. Priv.-Doz. Mag. rer. nat. PhD

The CCL20-dependent fibrotic niche: interactions between ATII cells, fibroblasts and immune cells

Deputy Chair of the Division of Pharmacology, Otto Loewi Research Center

Division of Pharmacology, Otto Loewi Research Centre, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz
Phone: +43-316-385 74105, ✉ e-mail

WWW: Forschungsportal Med Uni Graz
ORCID: 0000-0002-0870-0816
PubMed: PubMed (nih.gov)

• Profile      • Curriculum vitae     • Publications    
Education:
2020 Venia docendi (habilitation) in Pharmacology, Medical University of Graz, Austria
2008 – 2012 PhD thesis, PhD Program Molecular Medicine, Medical University of Graz, Austria (Graduation with Distinction)
2007 –2008 MSc degree, Studies of Molecular Microbiology, University of Graz, Austria (Graduation with Distinction)
2003 –2007 BSc degree, Studies of Molecular Biology, University of Graz, Austria
Positions:
2023 – present Associate Professor, Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Austria
2023 – present Deputy Chair of the Division of Pharmacology, Medical University of Graz, Austria
2018 – 2026 Consultant, Therycell and HSDiagnomics, Berlin, Germany
2020 – 2023 Assistant Professor, Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Austria
2017 – 2020 Junior group leader (Univ.-Ass.), Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Austria
2013 – 2016 Postdoctoral fellow, Fred Hutch, Seattle, USA (PI: A. M. Houghton)
2012 Postdoctoral fellow, Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria (PI: R. Schicho)
Significant research achievements and awards (10 most important):
  • FWF Project P35294 Nuclear function of secreted neutrophil elastase in NSCLC (381,000 €) (2022 – 2026)
  • Host and Mentor for FFG Spin-off Fellowship: Overseeing the direct evaluation of receptors in tissue-infiltrating lymphocytes (TILDER) (496,000 €) (2024 – 2025)
  • Co-PI Austrian Science Fund (doc.fund 129; RESPIMMUN), Collaborating on the role of neutrophil-derived myeloperoxidase (MPO) in lung cancer metastasis
  • Host and Mentor for MUG START Funding Grant: Directing research on metabolic reprogramming in neutrophils during lung cancer (2023 – 2024)
  • Speaker at IFPA: Montreal, Canada (2024)
  • Speaker at Redox Biology in Translation, Vienna, Austria (2023)
  • Speaker at the 45th FEBS Congress, online (2021)
  • Heribert Konzett Award, Austrian Pharmacological Society for excellence in pharmacological research (2019)
  • Hans Horst Meyer Award, recognized early-career excellence by the Austrian Pharmacological Society (2013)
  • Research Award of the Austrian Pain Society, honored for significant contributions to preclinical research (2014)

05.04.2026 CRONIC-PPF · Doctoral Programme “Clinical & Research Oriented Network for Innovative Classification of Progressive Pulmonary Fibrosis”